ZIVAX Diagnostics, Inc. (NYSE MKT: IVD), a fully integrated in vitro diagnostics company, announced today that its corporate name has been changed to "ERBA Diagnostics, Inc." The name change was approved by IVAX Diagnostics’ stockholders at the Annual Meeting of Stockholders held earlier today. IVAX Diagnostics' Board of Directors previously approved the name change, and recommended that the IVAX Diagnostics' stockholders approve the name change.
IVAX Diagnostics’ Board of Directors believes that the name change would be in the best interests of IVAX Diagnostics and its stockholders. The new name would reflect the strong relationship that IVAX Diagnostics enjoys with its majority stockholder — ERBA Diagnostics Mannheim GmbH, an emerging multi-national company operating in the core business segment of in vitro diagnostics.
In connection with the name change, the ticker symbol of IVAX Diagnostics' common stock, par value $0.01, on the NYSE MKT (formerly known as the NYSE Amex) will change from "IVD" to "ERB." Trading under the new ticker symbol, "ERB," is planned to begin at market-open on Monday, June 18, 2012.
Market Data 
Markets 
AI
